Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›
Home / Drugs / Encelto

Encelto, revakinagene taroretcel

Named-patient access overview. Encelto is coordinated by Reserve Meds for international patients via physician-led cross-border sourcing.

About Encelto

Encelto (revakinagene taroretcel) is manufactured by Neurotech and indicated for Macular telangiectasia type 2. It is a Encapsulated cell therapy approved by the US FDA in 2025 and may be accessible to international patients through Named Patient Program or personal-import pathways.

How Reserve Meds coordinates Encelto

  1. Patient or treating physician submits a named-patient request.
  2. Clinical team verifies appropriateness of Encelto for the patient and destination country.
  3. Treating physician issues prescription and clinical justification.
  4. Country-specific NPP / personal-import documentation is prepared.
  5. Encelto is sourced from a DSCSA-compliant US specialty wholesaler with full serial traceability.
  6. Shipment is coordinated to the patient's physician or hospital pharmacy (cold-chain where required).

Access by country

Reserve Meds publishes a detailed country deep-dive for Encelto in every market we coordinate. Each page below covers the destination-country regulatory pathway (named-patient framework), real costs in local currency and USD, indicative timelines, physician-credential requirements, and cold-chain handling for the route into that country. Tap any country to read the full deep-dive.

Encelto in BahrainFull deep-dive on regulatory pathway, costs, timing Encelto in BangladeshFull deep-dive on regulatory pathway, costs, timing Encelto in IndiaFull deep-dive on regulatory pathway, costs, timing Encelto in JordanFull deep-dive on regulatory pathway, costs, timing Encelto in KuwaitFull deep-dive on regulatory pathway, costs, timing Encelto in QatarFull deep-dive on regulatory pathway, costs, timing Encelto in Saudi ArabiaFull deep-dive on regulatory pathway, costs, timing Encelto in Sri LankaFull deep-dive on regulatory pathway, costs, timing

Start a request for Encelto

Submit a 60-second intake. Our clinical team will reach out as our first cohort opens with case-specific feasibility, timeline, and a formal quote.

Join the Encelto waitlist

About Encelto

Ophthalmology (MacTel)
Manufacturer: Neurotech
Modality: Encapsulated cell therapy
Generic: revakinagene taroretcel

Why Reserve Meds

DSCSA-compliant US sourcing. Physician-led. On-pathway in every destination. Patient-first intake with a named concierge.

Related

Access pathways
Country guidance
Articles & guides